Compiled by John T. Pichot 06/26/1998

Revised by Alan D. Schmetzer 10/10/2001

Quick Links 

Overview

Classic Contributions

Epidemiology

Neurobiology

Assessment and Screening

Treatment

Comorbid Issues

Public and Social Policy Issues

Medical Complications

Special Populations

1. Schmetzer AD, McGrath R: Phencyclidine (PCP) – Related Psychiatric Disorders, in e-Medicine Textbook of Medicine, Ob/Gyn, Psychiatry and Surgery, eds. Liskow BI, Talavera F, Ahmed I, Harsch HH, Soreff S, e-Medicine, Chicago, 2001 [www.emedicine.com]

2. Daghestani AN, Schnoll SH: Phencyclidine. Chapter 10 in The American Psychiatric Press Textbook of Substance Abuse Treatment, eds. Galanter M, Kleber HD. American Psychiatric Press, Washington D.C. 1994:149-156

1. Meyer JS, Greifenstein F, DeVault M: A New Drug Causing Symptoms of Sensory Deprivation. J Nerv Ment Dis 1959; 129:54-61

1. 1996 National Household Survey on Drug Abuse, Substance Abuse and Mental Health Services Administration, Office of Applied Studies, U.S. Department of Health and Human Services, August 1997 [www.health.org/pubs/nhsda/96hhs/index.htm]

1. Zukin SR, Sloboda Z, Javitt DC: Phencyclidine (PCP), Chapter 21 in Substance Abuse: A Comprehensive Textbook, Third Edition, eds. Lowinson JH, Ruiz P, Millman RB, Langrod JG. Williams & Wilkins, 1997:238-246

2. Lerma J, Zukin SR, Bennett MV: Interaction of Mg⁺⁺ and Phencyclidine in Use-Dependent Bloick of NMDA Channels. Neurosci Lett 1991; 244:187-191

1. Phencyclidine (or Phencyclidine-Like) - Related Disorders, in Diagnostic and Statistical Manual of Mental Disorders, fourth ed., Text Revision (DSM-IV-TR), 2000; 278-284

2. Slaby AE: Phencyclidine Intoxication, Delusional State, and Delirium, part of Chapter 5, Psychiatric Emergencies, in Handbook of Psychiatric Emergencies, fourth ed., Appleton & Lange, Norwalk, Connecticut, 1994; 340-343

1. Daghestani AN, Schnoll SH: Phencyclidine, Chapter 10 in The American Psychiatric Press Textbook of Substance Abuse Treatment, eds. Galanter M, Kleber HD. American Psychiatric Press, Washington D.C. 1994:149-156

2. Wilkins JN, Connor, BT, Gorelick DA: Phencyclidine (PCP), in Chapter 5, Management of Stimulant, Hallucinogen, Marijuana and Phencyclidine Intoxication and Withdrawal, from Principles of Addiction Medicine, second ed., American Society of Addiction Medicine, Chevy Chase, Maryland, 1998; 477-481

1. Caracci G, Migoni P, Mukherjee S: Phencyclidine Abuse and Depression. Pyschosomatics 1983; 24:932-933

2. Patel R, Connor G: A Review of Thirty Cases of Rhabdomyolysis-Associated Acute Renal Failure among Phencyclidine Users. Clin Toxicol 1986; 23:547-556

1. Olson DE, Lurigio AJ, Albertson S: Implementing the Key Components of Specialized Drug Treatment Courts:Practice and Policy Considerations. Law & Policy 2001; 23:171-196

1. McCarron MM, Schulze BW, Thompson GA: Acute Phencyclidine Intoxication: Clinical Patterns, Complications, and Treatment. Ann Emerg Med 1981; 10:290-297

1. Wilkins JN, Connor, BT, Gorelick DA: Special Populations, in Chapter 5, Management of Stimulant, Hallucinogen, Marijuana and Phencyclidine Intoxication and Withdrawal, from Principles of Addiction Medicine, second ed., American Society of Addiction Medicine, Chevy Chase, Maryland, 1998; 481-482

NIDA Phencyclidine Page [www.drugabuse.gov/DrugPage/pcp.html]

NIDA Infofax on PCP [www.drugabuse.gov/Infofax/pcp.html]

Bibliographies   Resource Listing by Subject   PGY-V Home